• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Liver function and energy metabolism in hepatocellular carcinoma developed in patients with hepatitis B-related cirrhosis.乙型肝炎相关肝硬化患者发生的肝细胞癌中的肝功能和能量代谢
Medicine (Baltimore). 2019 May;98(19):e15528. doi: 10.1097/MD.0000000000015528.
2
[Energy metabolism characteristic with risk of secondary bacterial infection in patients with hepatitis B virus-related chronic liver disease].[乙型肝炎病毒相关慢性肝病患者继发细菌感染风险的能量代谢特征]
Zhonghua Gan Zang Bing Za Zhi. 2021 Jun 20;29(6):558-564. doi: 10.3760/cma.j.cn501113-20210130-00052.
3
Efficacy of lamivudine therapy for decompensated liver cirrhosis due to hepatitis B virus with or without hepatocellular carcinoma.拉米夫定治疗乙型肝炎病毒所致失代偿期肝硬化伴或不伴肝细胞癌的疗效。
Oncol Rep. 2005 Jun;13(6):1159-63.
4
Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.增殖标志物Ki-67和p53蛋白在HBV或HCV肝硬化中的肝脏表达与发育异常肝细胞变化及肝细胞癌的关系。
J Viral Hepat. 2005 Nov;12(6):635-41. doi: 10.1111/j.1365-2893.2005.00635.x.
5
Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.乙型肝炎病毒相关性肝移植:适应证减少及趋势变化
World J Gastroenterol. 2015 Jul 14;21(26):8140-7. doi: 10.3748/wjg.v21.i26.8140.
6
Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus.肝癌合并糖尿病患者的国际标准化比值升高。
World J Gastroenterol. 2013 Apr 21;19(15):2395-403. doi: 10.3748/wjg.v19.i15.2395.
7
Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.乙肝和丙肝病毒合并感染与肝硬化患者肝细胞癌风险:一项前瞻性研究
Cancer. 1994 Nov 1;74(9):2442-8. doi: 10.1002/1097-0142(19941101)74:9<2442::aid-cncr2820740909>3.0.co;2-#.
8
Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.隐匿性乙型肝炎病毒感染和既往乙型肝炎病毒感染对丙型肝炎病毒所致肝硬化患者肝细胞癌发生的影响
Scand J Gastroenterol. 2008;43(7):849-56. doi: 10.1080/00365520801935459.
9
High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.尼泊尔肝硬化或肝细胞癌患者中乙肝病毒感染及下腔静脉阻塞的高患病率。
J Gastroenterol Hepatol. 2007 Nov;22(11):1921-8. doi: 10.1111/j.1440-1746.2006.04611.x.
10
Resting energy expenditure and substrate metabolism in Chinese patients with acute or chronic hepatitis B or liver cirrhosis.中国急性或慢性乙型肝炎及肝硬化患者的静息能量消耗和底物代谢
Intern Med. 2010;49(19):2085-91. doi: 10.2169/internalmedicine.49.3967. Epub 2010 Oct 1.

引用本文的文献

1
Prediction of effective percutaneous transhepatic biliary drainage in patients with hepatocellular carcinoma: A multi-central retrospective study.肝细胞癌患者有效经皮肝穿刺胆道引流的预测:一项多中心回顾性研究。
Liver Res. 2022 Dec 5;6(4):269-275. doi: 10.1016/j.livres.2022.11.008. eCollection 2022 Dec.
2
ALBI Grade Analyses of TACE Combined with Anti-Angiogenesis Therapies Plus PD-1 Inhibitors versus Anti-Angiogenesis Therapies Plus PD-1 Inhibitors in Advanced HCC.TACE联合抗血管生成疗法加PD-1抑制剂与抗血管生成疗法加PD-1抑制剂治疗晚期肝癌的ALBI分级分析
J Hepatocell Carcinoma. 2024 Dec 19;11:2505-2514. doi: 10.2147/JHC.S485867. eCollection 2024.
3
Screening of Cancer-Specific Biomarkers for Hepatitis B-Related Hepatocellular Carcinoma Based on a Proteome Microarray.基于蛋白质芯片筛选乙型肝炎相关肝细胞癌的癌症特异性生物标志物
Mol Cell Proteomics. 2024 Dec;23(12):100872. doi: 10.1016/j.mcpro.2024.100872. Epub 2024 Nov 1.
4
Energy Expenditure in Upper Gastrointestinal Cancers: a Scoping Review.上消化道癌症的能量消耗:一项范围综述。
Adv Nutr. 2023 Nov;14(6):1307-1325. doi: 10.1016/j.advnut.2023.08.002. Epub 2023 Aug 8.
5
HNF4α is possibly the missing link between epithelial-mesenchymal transition and Warburg effect during hepatocarcinogenesis.HNF4α 可能是肝癌发生过程中上皮-间充质转化和瓦博格效应之间缺失的环节。
Cancer Sci. 2023 Apr;114(4):1337-1352. doi: 10.1111/cas.15686. Epub 2022 Dec 19.
6
Effect of Entecavir Combined with Adefovir Dipivoxil on Clinical Efficacy and TNF- and IL-6 Levels in Patients with Hepatitis B Cirrhosis.恩替卡韦联合阿德福韦酯对乙型肝炎肝硬化患者临床疗效及肿瘤坏死因子和白细胞介素-6水平的影响
J Oncol. 2021 Aug 24;2021:9162346. doi: 10.1155/2021/9162346. eCollection 2021.
7
Transcriptomic Diversity in the Livers of South African Sardines Participating in the Annual Sardine Run.参与年度沙丁鱼洄游的南非沙丁鱼肝脏中的转录组多样性。
Genes (Basel). 2021 Mar 4;12(3):368. doi: 10.3390/genes12030368.
8
Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2.雷莫西尤单抗对晚期肝细胞癌患者ALBI分级的影响:REACH和REACH-2研究结果
JHEP Rep. 2020 Nov 13;3(2):100215. doi: 10.1016/j.jhepr.2020.100215. eCollection 2021 Apr.
9
Population Pharmacokinetics and Dosage Optimization of Linezolid in Patients with Liver Dysfunction.利奈唑胺在肝功能不全患者中的群体药代动力学及剂量优化
Antimicrob Agents Chemother. 2020 May 21;64(6). doi: 10.1128/AAC.00133-20.
10
Association between Albumin-Bilirubin Grade and Non-Protein Respiratory Quotient in Patients with Chronic Liver Diseases.慢性肝病患者白蛋白-胆红素分级与非蛋白呼吸商之间的关联
J Clin Med. 2019 Sep 18;8(9):1485. doi: 10.3390/jcm8091485.

本文引用的文献

1
Metabolic profiling of hepatitis B virus-related hepatocellular carcinoma with diverse differentiation grades.不同分化程度的乙型肝炎病毒相关肝细胞癌的代谢谱分析
Oncol Lett. 2017 Mar;13(3):1204-1210. doi: 10.3892/ol.2017.5596. Epub 2017 Jan 11.
2
Prognostic significance of nonprotein respiratory quotient in patients with liver cirrhosis.非蛋白呼吸商在肝硬化患者中的预后意义
Medicine (Baltimore). 2017 Jan;96(3):e5800. doi: 10.1097/MD.0000000000005800.
3
Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements.人血清白蛋白稳态:对合成、分解代谢、肾脏和胃肠道排泄作用的新认识以及血清白蛋白测量的临床价值。
Int J Gen Med. 2016 Jul 15;9:229-55. doi: 10.2147/IJGM.S102819. eCollection 2016.
4
The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China.γ-谷氨酰转肽酶与血小板比值在诊断慢性乙型肝炎患者显著纤维化和肝硬化方面并不优于APRI和Fib-4:一项中国的回顾性队列研究
Medicine (Baltimore). 2016 Apr;95(16):e3372. doi: 10.1097/MD.0000000000003372.
5
A Hepatocellular Carcinoma Aggressiveness Index and Its Relationship to Liver Enzyme Levels.一种肝细胞癌侵袭性指数及其与肝酶水平的关系。
Oncology. 2016;90(4):215-20. doi: 10.1159/000444394. Epub 2016 Mar 15.
6
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
7
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update.《亚太地区慢性乙型肝炎管理共识声明:2012年更新版》
Hepatol Int. 2012 Jun;6(3):531-61. doi: 10.1007/s12072-012-9365-4. Epub 2012 May 17.
8
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
9
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study.碱性磷酸酶和胆红素水平是原发性胆汁性肝硬化患者结局的替代终点:一项国际随访研究。
Gastroenterology. 2014 Dec;147(6):1338-49.e5; quiz e15. doi: 10.1053/j.gastro.2014.08.029. Epub 2014 Aug 23.
10
γ-Glutamyltranspeptidase is a prognostic marker of survival and recurrence in radiofrequency-ablation treatment of hepatocellular carcinoma.γ-谷氨酰转肽酶是肝细胞癌射频消融治疗中生存和复发的预后标志物。
Ann Surg Oncol. 2014 Sep;21(9):3084-9. doi: 10.1245/s10434-014-3724-4. Epub 2014 Apr 21.

乙型肝炎相关肝硬化患者发生的肝细胞癌中的肝功能和能量代谢

Liver function and energy metabolism in hepatocellular carcinoma developed in patients with hepatitis B-related cirrhosis.

作者信息

Ren Meixin, Li Juan, Xue Ran, Wang Zhongying, Coll Shengli Li, Meng Qinghua

机构信息

Department of Critical Care Medicine of Liver Disease, Beijing You-An Hospital.

Department of Gastroenterology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.

出版信息

Medicine (Baltimore). 2019 May;98(19):e15528. doi: 10.1097/MD.0000000000015528.

DOI:10.1097/MD.0000000000015528
PMID:31083199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6531143/
Abstract

Energy metabolism in patients with Hepatocellular carcinoma (HCC) accompanying by hepatitis B cirrhosis is unknown.To compare the differences in liver functions and energy metabolism between patients with hepatitis B-related cirrhosis and patients with HCC.This was a retrospective study of patients with hepatitis B-related cirrhosis (LC group, n = 75) and patients with HCC accompanying by hepatitis B cirrhosis (HCC group, n = 80) treated in Beijing You'an Hospital between January 2013 and June 2017. The resting energy expenditure (REE), respiratory quotient (RQ), carbohydrate oxidation rate (CHO%), fat oxidation rate (FAT%), and protein oxidation rate (PRO%) were measured using a metabolic cart. Liver function, renal function, blood coagulation, etc. were collected.Compared to the LC group, patients with HCC had normal metabolism, but RQ (0.83 ± 0.07 vs 0.85 ± 0.08, P = .073) and CHO% (35.5% vs 49%, P = .013) were lower and FAT% was higher (41% vs 33%, P = .030). Compared with patients with LC group, albumin (ALB), γ-glutamyltranspeptadase (GGT), alkaline phosphatase (AKP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and prothrombin time activity (PTA) were elevated in the HCC group, while total bilirubin (TB), total bile acid (TBA), and international normalized ratio (INR) were reduced (P < .05). Cholinesterase (CHE) was positively correlated with RQ, CHO, and CHO% (P < .05), while negatively correlated with FAT and FAT% (P < .05). AKP was negatively correlated with RQ, CHO, and CHO% (P < .05), while positively correlated with FAT and FAT% (P < .05). TBA was negatively correlated with RQ and CHO (P < .05), while positively correlated with FAT (P < .05).HCC leads to increased liver synthetic function and improve the liver functions of patients with LC, at least to some extent, but the nutritional metabolism was poor.

摘要

伴有乙型肝炎肝硬化的肝细胞癌(HCC)患者的能量代谢情况尚不清楚。为比较乙型肝炎相关性肝硬化患者与HCC患者的肝功能及能量代谢差异。这是一项对2013年1月至2017年6月在北京佑安医院接受治疗的乙型肝炎相关性肝硬化患者(LC组,n = 75)和伴有乙型肝炎肝硬化的HCC患者(HCC组,n = 80)的回顾性研究。使用代谢车测量静息能量消耗(REE)、呼吸商(RQ)、碳水化合物氧化率(CHO%)、脂肪氧化率(FAT%)和蛋白质氧化率(PRO%)。收集肝功能、肾功能、凝血等指标。与LC组相比,HCC患者代谢正常,但RQ(0.83±0.07 vs 0.85±0.08,P = 0.073)和CHO%(35.5% vs 49%,P = 0.013)较低,FAT%较高(41% vs 33%,P = 0.030)。与LC组患者相比,HCC组白蛋白(ALB)、γ-谷氨酰转肽酶(GGT)﹑碱性磷酸酶(AKP)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)和凝血酶原时间活动度(PTA)升高,而总胆红素(TB)、总胆汁酸(TBA)和国际标准化比值(INR)降低(P < 0.05)。胆碱酯酶(CHE)与RQ、CHO及CHO%呈正相关(P < 0.05),而与FAT及FAT%呈负相关(P < 0.05)。AKP与RQ、CHO及CHO%呈负相关(P < 0.05),而与FAT及FAT%呈正相关(P < 0.05)。TBA与RQ和CHO呈负相关(P < 0.05),而与FAT呈正相关(P < 0.05)。HCC导致肝脏合成功能增强,至少在一定程度上改善了LC患者的肝功能,但营养代谢较差。